2. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol 2015;235:323–333.
3. Cristescu R, Lee J, Nebozhyn M, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 2015;21:449–456.
5. Kim YS, Nam SC, Han MH, et al. Predictive factors of Epstein-Barr virus association in gastric adenocarcinoma. Korean J Pathol 2008;42:193–197.
7. Matsusaka K, Kaneda A, Nagae G, et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res 2011;71:7187–7197.
8. Shinozaki-Ushiku A, Kunita A, Fukayama M. Update on Epstein-Barr virus and gastric cancer (review). Int J Oncol 2015;46:1421–1434.
9. Lee M, Ryu E, Sung GH, et al. Current trends in studies of Epstein-Barr virus (EBV) associated gastric carcinoma. J Bacteriol Virol 2015;45:262–271.
12. Camargo MC, Koriyama C, Matsuo K, et al. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer 2014;134:948–953.
13. Cárdenas-Mondragón MG, Carreón-Talavera R, CamorlingaPonce M, et al. Epstein Barr virus and
Helicobacter pylori coinfection are positively associated with severe gastritis in pediatric patients. PLoS One 2013;8:e62850.
14. Lee JH, Kim SH, Han SH, et al. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol 2009;24:354–365.
15. Kim SY, Park C, Kim HJ, et al. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes. Gastroenterology 2015;148:137–147.e9.
16. Boysen T, Friborg J, Stribolt K, et al. Epstein-Barr virus-associated gastric carcinoma among patients with pernicious anemia. Int J Cancer 2011;129:2756–2760.
19. Tak DH, Jeong HY, Seong JK, Moon HS, Kang SH. Comparison of clinical characteristics and prognostic factors between gastric lymphoepithelioma-like carcinoma and gastric adenocarcinoma. Korean J Gastroenterol 2013;62:272–277.
20. Song HJ, Srivastava A, Lee J, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology 2010;139:84–92; e2.
21. Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int 2010;60:337–350.
22. Nishikawa J, Yanai H, Mizugaki Y, Takada K, Tada M, Okita K. Case report: hypoechoic submucosal nodules: a sign of Epstein-Barr virus-associated early gastric cancer. J Gastroenterol Hepatol 1998;13:585–590.
25. Camargo MC, Kim WH, Chiaravalli AM, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 2014;63:236–243.
27. Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer 1976;38:232–243.
29. Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer 1996;77:1998–2004.
30. Huang SC, Ng KF, Chen KH, et al. Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis. Oncol Rep 2014;32:530–538.